Concepedia
Statistics
Publications
19
Citations
1.4K
H-Index
14
Active since
2002
Affiliations
Eli Lilly (United States)(Current)
University of Michigan
PAREXEL International (United States)
Eli Lilly (Singapore)
Eli Lilly (Japan)
Dustin J. Mergott is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neurology.
Top concepts
MedicinePharmacologyNeurologyDrug DiscoveryNeuroprotectionAlzheimer's DiseaseBiochemistryNeuroscienceNeuropharmacologyDrug Development
Publications per year
2002–2024
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 365 citations · Full text
Robust Central Reduction, Amyloid-β Peptide, Neurochemical Biomarkers +21
The Vinylogous Intramolecular Morita−Baylis−Hillman Reaction: Synthesis of Functionalized Cyclopentenes and Cyclohexenes with Trialkylphosphines as Nucleophilic Catalysts
Scott A. Frank, Dustin J. Mergott, William Roush · Journal of the American Chemical Society · 2002 · 227 citations
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 195 citations · Full text
Amyloid β, Neurodegenerative Diseases, Amyloid Lowering +15
Catalytic Asymmetric Total Synthesis of (+)-Yohimbine
Dustin J. Mergott, Stephan J. Zuend, Eric N. Jacobsen · Organic Letters · 2008 · 157 citations
Absolute Configuration, Engineering, Total Synthesis +8
Total synthesis of (–)-spinosyn A
Dustin J. Mergott, Scott A. Frank, William Roush · Proceedings of the National Academy of Sciences · 2004 · 131 citations · Full text
1–5 of 19